SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-371049
Filing Date
2015-11-09
Accepted
2015-11-09 07:39:30
Documents
4
Period of Report
2015-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d14038d8k.htm 8-K 15010
2 EX-99.1 d14038dex991.htm EX-99.1 65659
3 GRAPHIC g14038ex99_1bottom.jpg GRAPHIC 3537
4 GRAPHIC g14038ex99_1logo.jpg GRAPHIC 10835
  Complete submission text file 0001193125-15-371049.txt   101893
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 151213986
SIC: 2834 Pharmaceutical Preparations